A potential breakthrough in the treatment of type 1 mediated chronic inflammatory skin diseases (ISD) has emerged, as ...

RIPK1 inhibition reduced inflammation and keratinocyte cell death in lichen planus and CLE models. Could this be a new ...

AbbVie announces US FDA approves combination treatment of Venclexta and acalabrutinib for previously untreated patients with CLL: North Chicago, Illinois Monday, February 23, 2026 ...

Researchers discover that hearing-essential proteins (TMC1/TMC2) also regulate cell membranes, and their malfunction is a primary cause of permanent hearing loss.

New research from Memorial Sloan Kettering Cancer Center (MSK) investigates harnessing the power of ferroptosis to spread cell death; reports how an ...

With cancer cases rising sharply across India, the search for more precise, less invasive and patient-friendly treatments has intensified. From robotic surgery ...

A team of researchers has clarified a biological process first observed more than 50 years ago: how tissues rebuild themselves after severe damage. The findings reveal that enzymes linked to cell ...

As is often the case with cancer treatments, many patients are able to benefit from therapy for a time. Tumor activity ...

A multiple myeloma candidate with a new mode of action is now in Phase 2 patient trials following positive Phase 1 results showing it kills cancer ...

Researchers reveal that eosinophils suppress chordoma growth, highlighting its potential as an immunotherapeutic target ...

New study reveals how cytoplasmic and nuclear functions of USP30-AS1 converge to promote tumor growth Breast cancer progression is increasingly ...